Kynexis Therapeutics
PrivateLast Round
Series A
Aug 19, 2026
Total Funding Raised
$220M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Kynexis Therapeutics is a biotechnology company developing precision therapeutics for brain diseases, with a focus on cognitive impairment associated with schizophrenia (CIAS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kynexis Therapeutics Comparables
Compare Kynexis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurosterix | 83% | |
| Phrenix Therapeutics | 80% | |
| Alto Neuroscience | 79% |
Kynexis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 19, 2026 | ||||
| Series A | Nov 7, 2023 |
Kynexis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Series A |
| Ysios Capital | Series A |
| Sunstone Life Science Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2026
$110M round led by nvfund
- Jul 24, 2026
Monthly visitors grew 181% MoM, reaching 2K.
Recent news
Latest coverage and updates
- hiresAug 21, 2026
Kynexis hires John McDonald as advisor.
- receives_financingAug 19, 2026
Kynexis received financing of $46.3M in Series A on Aug 21st '26.
- hiresAug 19, 2026
Kynexis hired Mathias Frederiksen as Board Observer on Aug 19th '26.
- receives_financingAug 19, 2026
Kynexis received financing of $46.3M in Series A1 on Aug 19th '26.
- hiresAug 19, 2026
Kynexis hired Marianne Uteng as Board of Directors on Aug 19th '26.
Kynexis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kynexis Therapeutics's valuation, stock price, and market status.
Is Kynexis Therapeutics a public or private company?
Kynexis Therapeutics is a private company.
What is the current stock price of Kynexis Therapeutics?
Kynexis Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Kynexis Therapeutics worth (valuation)?
Valuation information for Kynexis Therapeutics is not publicly available.
Can I buy Kynexis Therapeutics stock?
Kynexis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kynexis Therapeutics's last funding round?
Kynexis Therapeutics's most recent funding round was Series A on November 7, 2023.
Who are the main investors in Kynexis Therapeutics?
Key investors in Kynexis Therapeutics include Forbion.
Will Kynexis Therapeutics IPO soon?
No public IPO plans have been announced for Kynexis Therapeutics.
How can I track Kynexis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kynexis Therapeutics's secondary market activity and sign up for updates.